Article
Exosome-transmitted HSPA9 facilitates bortezomib resistance by targeting TRIP13/USP1 signaling in multiple myeloma
26 Mar 2025
Abstract excerpt
Resistance to the proteasome inhibitor bortezomib (BTZ) poses a formidable therapeutic challenge in multiple myeloma (MM). Our study aims to analyze the mechanism by which exosomes heat shock 70 kDa protein 9 (HSPA9) secreted by BTZ-resistant MM cells disseminate resistance to BTZ-sensitive MM cells. The serum exosomes were identified by nanoparticle tracking analysis and transmission electron microscopy. Liquid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
